Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial
Status:
Completed
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center,
double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic
efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in
subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.